This invention relates to novel N-hydroxyacrylamide compounds of formula (I) and pharmaceutically acceptable salts thereof. More particularly, it relates to novel N-hydroxyacrylamide compounds and pharmaceutically acceptable salts thereof which act as a HDAC inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of HDAC-related disease. ##STR00001##

 
Web www.patentalert.com

< HDAC INHIBITOR

> Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases

> New Use 938

~ 00502